Revvity Faced Off With 'Elevated Investor Expectations' — And Won

Medical research stock Revvity surged on the back of a strong third-quarter report and heightened 2026 view. The post Revvity Faced Off With 'Elevated Investor Expectations' — And Won appeared first on Investor's Business Daily.